• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Recap From the 2023 SDPA Annual Summer Dermatology Conference

Article

If you weren’t able to attend the 2023 Society of Dermatology Physician Assistants (SDPA) Annual Summer Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.

Kürşat Ünsal/AdobeStock
Kürşat Ünsal/AdobeStock

POLL: Are You Attending SDPA Summer 2023?

Click here to answer this week's poll.

Previewing the SDPA Annual Summer Dermatology Conference: What to Expect

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.

POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2023?

Click here to answer today's poll.

Plan Your Trip: What to do While Visiting Boston

When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.

Discussing Clinical Pearls in Dermatology With Omar Noor, MD, FAAD

Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."

Brodalumab Demonstrates Quality of Life, Mental Health Improvement in Patients Regardless of Prior Biologic Use

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.

Emphasizing Culturally Competent Care in Patients With Skin of Color

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

Tazarotene Led to Hyperpigmentation Improvement in Black Patients With Acne

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

New and Promising Drugs in Inflammatory Dermatoses

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

Sights and Sounds of the SDPA Annual Summer Dermatology Conference: Day 1

Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.

SDPA Annual Summer Dermatology Conference Recap: Day 1

Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.

Reviewing Considerations for Pigmentary Disorders With Nicole Gunasekera, MD, MBA

Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.

Rising Antifungal Resistance Poses a Threat to Onychomycosis Treatment

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.

Skin Cancer in the Realm of Inflammatory Dermatoses

Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.

John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica

In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.

Renata Block, MMS, PA-C, Discusses the Role of the Dermatology PA Foundation in Supporting Physician Assistants

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement

Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.

SDPA Annual Summer Dermatology Conference Recap: Day 2

Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.

Conservative Imputation Method Efficacious in Moderate-to-Severe Hidradenitis Suppurativa

With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.

Abrocitinib Did Not Impact Immune Responses to Vaccination in Adolescents With Atopic Dermatitis

A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.

Recognizing and Treating Hidradenitis Suppurativa With Joslyn Kirby, MD

Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.

Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE

Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.

Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.

SDPA Annual Summer Dermatology Conference Recap: Day 3

Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.

Dupilumab Improved Itch and Pain in Adults With Prurigo Nodularis

The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.

Arash Mostaghimi, MD, MPA, MPH: Pearls in Dermatopathology and Alopecia

Arash Mostaghimi, MD, MPA, MPH, provides a comprehensive overview of his SDPA conference sessions, "Understanding the Pathology Report and Basic Biopsies," "Beyond the H&E," and "Alopecia: Treating Challenging Cases."

Jane Mast, PhD, DMSc, MPAS: Empathy in the Patient Journey With HS

Jane Mast, PhD, DMSc, MPAS, discusses empathetic care in hidradenitis suppurativa and the importance of supporting patients with HS in every step of their journey with the condition.

The Future of Non-Invasive Skin Cancer Removal

Orit Markowitz, MD, discusses the future of non-invasive lasers in removing skin cancer and cancerous lesions, ultimately allowing patients to leave the practice without a bandaid.

Looking Ahead to the Future of Dermatology

As SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.

Photo Gallery: SDPA Annual Summer Dermatology Conference 2023

Want to reminisce on your time on Boston? View our conference photo gallery below.

SDPA Annual Summer Dermatology Conference Recap: Day 4

Catch up on coverage from the fourth and final day of the 2023 SDPA Annual Summer Dermatology Conference.

POLL: What Did You Take Away From SDPA Summer 2023?

Click here to answer today's poll.

For a full list of conference coverage from the SDPA Annual Summer Dermatology Conference, visit our conference page.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.